These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Pulmonary eosinophilia associated with valproic acid]. San Miguel López de Uralde SM; Prieto Peraita M; Blanco Bengoechea EJ Med Clin (Barc); 2015 Jun; 144(11):527-8. PubMed ID: 25261274 [No Abstract] [Full Text] [Related]
7. Adding lithium or anticonvulsants to antipsychotics for the treatment of schizophrenia: useful strategy or exercise in futility? Citrome L J Clin Psychiatry; 2009 Jun; 70(6):932-3. PubMed ID: 19573487 [No Abstract] [Full Text] [Related]
8. Eosinophilic pleural effusion associated with valproic acid administration. Kaufman J; O'Shaughnessy IM South Med J; 1995 Aug; 88(8):881-2. PubMed ID: 7631223 [TBL] [Abstract][Full Text] [Related]
10. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate]. Roncoroni D Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121 [TBL] [Abstract][Full Text] [Related]
11. Reversible cerebral atrophy: a case report and literature review. Thirugnanasampanthan U; Foster A; Rauch RA Gen Hosp Psychiatry; 2006; 28(5):458-62. PubMed ID: 16950389 [No Abstract] [Full Text] [Related]
12. Edema associated with addition of risperidone to valproate treatment. Sanders RD; Lehrer DS J Clin Psychiatry; 1998 Dec; 59(12):689-90. PubMed ID: 9921707 [No Abstract] [Full Text] [Related]
13. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia. Levinson I; Levine S Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667 [No Abstract] [Full Text] [Related]
14. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Bullington W; Sahn SA; Judson MA Am J Med Sci; 2007 May; 333(5):290-2. PubMed ID: 17505171 [TBL] [Abstract][Full Text] [Related]
15. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia. Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697 [TBL] [Abstract][Full Text] [Related]
16. Three medication pathways for bipolar disorder. Blake T Nursing; 2012 May; 42(5):28-35; quiz 35-6. PubMed ID: 22488206 [No Abstract] [Full Text] [Related]